Guide: How research is recorded

Trial phases

A trial's phase is a label for its stage in the testing of a drug or biological product, from the first small studies in people (Phase 1) to large late-stage studies (Phase 3) and studies after approval (Phase 4).

This entry has not yet been checked by a person. It was written by software from the sources it lists. What “checked by a person” means

In the records

The phase is a field in a trial’s registry record, chosen by the sponsor. ClinicalTrials.gov bases it on definitions developed by the United States Food and Drug Administration (FDA), and says it reflects the study’s objective and number of participants.

In its glossary, Phase 1 trials focus on a drug’s safety, usually in a small number of people. Phase 2 trials gather preliminary data on whether the drug works in people with a certain condition. The FDA describes Phase 3 studies as involving 300 to 3,000 volunteers with the condition, to study efficacy and monitor adverse reactions. Phase 4 comes after approval.

A record can also read “Early Phase 1”, a combination such as “Phase 1/Phase 2”, or “N/A”.

What it does not tell you

A phase is not a score. A higher phase says what kind of study has started, not what it found.

“N/A” does not mean early or unknown. It is used for trials with no FDA-defined phase, such as those of devices or behavioural interventions.

The sources count differently, and the participant numbers are typical ranges, not rules. The European Medicines Agency speaks of usually three phases before authorisation, and says that for rare diseases a Phase 3 trial may not always be carried out.

On this site

A status follows the furthest trial that counts and has started. “Phase 1 trial”, “Phase 2 trial” and “Phase 3 trial” each name that trial's phase as its registry record gives it. A record with no phase gives “Trial registered”. The rule: How a status is set

Sources

Something wrong on this page? Tell us what, and the source that shows it: Report an error (opens your mail)